Past Meeting | Keystone Symposia

Program


Sunday, February 23 \| 4:00PM - 8:00PM Arrival and Registration Room: Van Horne Foyer
Sunday, February 23 \| 6:00PM - 8:00PM Welcome Mixer Room: Van Horne Foyer No registration fees are used to fund alcohol served at this function.
Monday, February 24 \| 7:00AM - 8:00AM Breakfast Room: Van Horne B/C
Monday, February 24 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Van Horne A Speaker 1 of 2 * Rebecca A. Haeusler, Columbia University, USA
Monday, February 24 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Van Horne A Speaker 2 of 2 Mitchell A. Lazar, Perelman School of Medicine, University of Pennsylvania, USA The Fourth Dimension of Obesity and NAFLD
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Speaker 1 of 7 * Maaike Oosterveer, University Medical Center Groningen, Netherlands
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Speaker 2 of 7 Kun-Liang Guan, University of California, San Diego, USA The Hippo Pathway in Metabolism and Organ Growth
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Coffee Break
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Speaker 4 of 7 Hannele Yki-Järvinen, University of Helsinki, Finland Function of the PNPLA3 I148M Gene Variant in the Human Liver
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Speaker 5 of 7 Mark A. Herman, Duke University Medical Center, USA Molecular Aspects of Fructose-Induced Metabolic Dysregulation
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Speaker 6 of 7 Lei Yin, University of Michigan Medical School, USA Short Talk: DDB1 E3 Ligase Links Dietary Fructose Intake and ChREBP Protein Stabilization and Enhanced De Novo Lipogenesis via CRY1 Degradation
Monday, February 24 \| 9:00AM - 11:30AM New Pathways in Hepatic Metabolism Room: Van Horne A Speaker 7 of 7 Jennifer L. Estall, Institut de Recherches Cliniques de Montréal, Canada Short Talk: Glucagon Enhances Insulin-Mediated Suppression of Gluconeogenesis by Regulating the IRS1:IRS2 Ratio via PGC1A
Monday, February 24 \| 11:30AM - 5:00PM On Own for Lunch
Monday, February 24 \| 11:30AM - 1:00PM Poster Setup Room: Van Horne B/C
Monday, February 24 \| 1:00PM - 10:00PM Poster Viewing Room: Van Horne B/C
Monday, February 24 \| 2:30PM - 4:30PM Career Roundtable Room: DC Coleman Interested participants must sign up at the registration desk on a first-come, first-serve basis. Maximum attendance: 60. Speaker 1 of 5 Claudio J. Villanueva, University of California, Los Angeles, USA
Monday, February 24 \| 2:30PM - 4:30PM Career Roundtable Room: DC Coleman Interested participants must sign up at the registration desk on a first-come, first-serve basis. Maximum attendance: 60. Speaker 2 of 5 Alan Morris, Nature Reviews Endocrinology, Germany
Monday, February 24 \| 2:30PM - 4:30PM Career Roundtable Room: DC Coleman Interested participants must sign up at the registration desk on a first-come, first-serve basis. Maximum attendance: 60. Speaker 3 of 5 Yaron Rotman, NIDDK, National Institutes of Health, USA
Monday, February 24 \| 2:30PM - 4:30PM Career Roundtable Room: DC Coleman Interested participants must sign up at the registration desk on a first-come, first-serve basis. Maximum attendance: 60. Speaker 4 of 5 Jun Wu, University of Michigan, USA
Monday, February 24 \| 2:30PM - 4:30PM Career Roundtable Room: DC Coleman Interested participants must sign up at the registration desk on a first-come, first-serve basis. Maximum attendance: 60. Speaker 5 of 5 Silvia Corvera, University of Massachusetts Medical School, USA
Monday, February 24 \| 4:30PM - 5:00PM Coffee Available Room: Van Horne Foyer
Monday, February 24 \| 5:00PM - 7:00PM Mitochondrial Function in Energy Balance and Metabolic Disea se Room: Van Horne A Speaker 1 of 6 * Shingo Kajimura, Harvard Medical School, Beth Israel Deaconess Medical Center, USA
Monday, February 24 \| 5:00PM - 7:00PM Mitochondrial Function in Energy Balance and Metabolic Disea se Room: Van Horne A Speaker 2 of 6 Brian N. Finck, Washington University School of Medicine, USA Targeting Mitochondrial Intermediary Metabolism to Treat NAFLD
Monday, February 24 \| 5:00PM - 7:00PM Mitochondrial Function in Energy Balance and Metabolic Disea se Room: Van Horne A Speaker 3 of 6 Maren C. Podszun, NIDDK, National Institutes of Health, USA Short Talk: Vitamin E Treatment in NAFLD Reveals Novel Pathway: Oxidative Stress Drives De-Novo Lipogenesis Through S1P/S2P Proteases
Monday, February 24 \| 5:00PM - 7:00PM Mitochondrial Function in Energy Balance and Metabolic Disea se Room: Van Horne A Speaker 4 of 6 Douglas G. Mashek, University of Minnesota, USA Lipid Droplet Signaling as a Driver of Mitochondrial Metabolism
Monday, February 24 \| 5:00PM - 7:00PM Mitochondrial Function in Energy Balance and Metabolic Disea se Room: Van Horne A Speaker 5 of 6 Jun Wu, University of Michigan, USA Nicotinic Acetylcholine Receptors in Energy Metabolism
Monday, February 24 \| 5:00PM - 7:00PM Mitochondrial Function in Energy Balance and Metabolic Disea se Room: Van Horne A Speaker 6 of 6 Lawrence Kazak, McGill University, Canada Short Talk: Creatine Energetics in Brown Fat Controls Energy Expenditure through Creatine Kinase B-Type
Monday, February 24 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Van Horne B/C No registration fees are used to fund alcohol served at this function.
Monday, February 24 \| 7:30PM - 10:00PM Poster Session 1 Room: Van Horne B/C
Tuesday, February 25 \| 7:00AM - 8:00AM Breakfast Room: Van Horne B/C
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 1 of 8 Christopher B. Newgard, Duke University Medical Center, USA Hepatic Metabolic Regulatory Nodes Linked to Cardiometabolic Diseases
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 2 of 8 Claudio J. Villanueva, University of California, Los Angeles, USA Adipose-Liver Crosstalk and Adaptive Thermogenesis
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Coffee Break
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 4 of 8 Rebecca A. Haeusler, Columbia University, USA Bile Acid Regulation of Metabolism
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 5 of 8 Annelise Poss, University of Utah, USA Short Talk: Ceramides as Lipotoxic Mediators of Non-Alcoholic Fatty Liver Disease and Steatohepatitis
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 6 of 8 * James C. Lo, Weill Cornell Medicine, USA Short Talk: An Adipose Regulator of Beta Cell Failure
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 7 of 8 Maaike Oosterveer, University Medical Center Groningen, Netherlands Short Talk: Hepatic ChREBP Activation Limits NAFLD Development in a Mouse Model for GSD Ia
Tuesday, February 25 \| 8:00AM - 11:00AM Metabolites Mediating Tissue Crosstalk Room: Van Horne A Speaker 8 of 8 Kirk M. Habegger, University of Alabama, Birmingham, USA Short Talk: Title to be Announced
Tuesday, February 25 \| 11:00AM - 5:00PM On Own for Lunch
Tuesday, February 25 \| 11:00AM - 1:00PM Poster Setup Room: Van Horne B/C
Tuesday, February 25 \| 1:00PM - 10:00PM Poster Viewing Room: Van Horne B/C
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 1 of 9 * Claudio J. Villanueva, University of California, Los Angeles, USA
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 2 of 9 Andrea Galmozzi, The Scripps Research Institute, USA Intracellular Heme Trafficking in Adipocytes Regulates Energy Homeostasis
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 3 of 9 Lucia Korinkova, Czech Academy of Sciences, Czech Republic Impact of Lipidized Prolactin-Releasing Peptide Treatment on Metabolic Syndrome and Leptin-Related Signaling Pathways in Three Mouse Models
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 4 of 9 Iichiro Shimomura, Osaka University, Japan Action Mechanism of High-Molecular Weight Multimer Adiponectin – Possible Role of Stem Cells, T-Cadherin, and Exosomes for Organ Protections
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 5 of 9 Mohammad Abu Odeh, University of California, San Diego, USA FGF21 Acts Locally on the Adipose Tissue to Induce Weight Loss
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 6 of 9 Ludger Scheja, University Medical Center Hamburg-Eppendorf, Germany The Role of the Alternative Pathway-Derived Bile Acids in NAFLD Progression
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 7 of 9 Abraham Stijn Meijnikman, Amsterdam University Medical Center, Netherlands Hyperinsulinemia, a Key Player in Visceral Adipose Tissue and Hepatic Cellular Senescence
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 8 of 9 Yohei Kanamori, Nagoya University, Japan Role of Iron in the Emergence of Proinflammatory and Profibrotic Macrophages in a Mouse Model of Nonalcoholic Steatohepatitis
Tuesday, February 25 \| 2:30PM - 4:30PM Workshop 1: Late-Breaking Research in Obesity and NAFLD Room: Van Horne A Speaker 9 of 9 WonGun Choi, Korea Advanced Institute of Science and Technology, South Korea The Role of Serotonin Signaling through HTR2A/2B in Visceral Adipose Tissue
Tuesday, February 25 \| 4:30PM - 5:00PM Coffee Available Room: Van Horne Foyer
Tuesday, February 25 \| 5:00PM - 7:00PM Drivers of NAFLD and Dyslipidemia in Obesity Room: Van Horne A Speaker 1 of 6 * Masahiro Koseki, Osaka University, Japan
Tuesday, February 25 \| 5:00PM - 7:00PM Drivers of NAFLD and Dyslipidemia in Obesity Room: Van Horne A Speaker 2 of 6 Elizabeth J. Parks, University of Missouri, USA Liver Metabolic Flux in NAFLD and NASH
Tuesday, February 25 \| 5:00PM - 7:00PM Drivers of NAFLD and Dyslipidemia in Obesity Room: Van Horne A Speaker 3 of 6 Greg Steinberg, McMaster University, Canada Cellular Energy Sensing and Metabolism: Implications for Treating NAFLD
Tuesday, February 25 \| 5:00PM - 7:00PM Drivers of NAFLD and Dyslipidemia in Obesity Room: Van Horne A Speaker 4 of 6 Lale Ozcan, Columbia University, USA Glucagon-Mediated Regulation of Cholesterol Metabolism
Tuesday, February 25 \| 5:00PM - 7:00PM Drivers of NAFLD and Dyslipidemia in Obesity Room: Van Horne A Speaker 5 of 6 Onno Holleboom, Amsterdam UMC, Netherlands Short Talk: Deficiency of V-ATPase Assembly Factors TMEM199 and CCDC115 Results in Hepatic Steatosis and Hyperlipidemia and May Affect Fusion of Lipid Droplets and Lysosomes
Tuesday, February 25 \| 5:00PM - 7:00PM Drivers of NAFLD and Dyslipidemia in Obesity Room: Van Horne A Speaker 6 of 6 Maria Chondronikola, University of California, Davis, USA Short Talk: Brown Adipose Tissue is Linked to Very-Low-Density Lipoprotein Triglyceride Metabolism in People
Tuesday, February 25 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Van Horne B/C No registration fees are used to fund alcohol served at this function.
Tuesday, February 25 \| 7:30PM - 10:00PM Poster Session 2 Room: Van Horne B/C
Wednesday, February 26 \| 7:00AM - 8:00AM Breakfast Room: Van Horne B/C
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 1 of 10 * Raymond E. Soccio, University of Pennsylvania, USA
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 2 of 10 Alexei Kharitonenkov, Novo Nordisk, USA Novel FGF21 Variants
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 3 of 10 Hank Mansbach, 89bio, USA BIO89-100, a Long-Acting FG21 Analog, for Treatment of NASH and Cardio-Metabolic Disorders
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Coffee Break
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 5 of 10 Timothy Rolph, Akero Therapeutics, Inc., USA Short Talk: AKR-001, a Long-Acting, Degradation-Resistant FGF21 Analog, Elicits Sustained Improvements in Markers of Glycemic Control and Lipid Metabolism in a 4-Week, Multiple Ascending Dose Study
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 6 of 10 Maria E. Wilson, Genentech, Inc., USA Short Talk: An Anti-FGFR1/KLB Bispecific Antibody Improves Lipid Profile, Markers of Fibrogenesis, and Liver Health in Patients with Type 2 Diabetes (T2DM) and Decreases Hepatic Fat in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 7 of 10 Lotte Bjerre Knudsen, Novo Nordisk A/S, Denmark GLP-1 Receptor Agonists: Mechanisms Relevant for the Treatment of Obesity and NASH
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 8 of 10 Asger Bach Lund, University of Copenhagen, Denmark Short Talk: The Effects of GIP on Food Intake, Energy Expenditure and Plasma Glucose in Patients with Type 2 Diabetes Treated with a Long-acting GLP-1 Receptor Agonist
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 9 of 10 Bruce L. Riser, BLR Bio, USA Short Talk: CCN3-Based Peptide Inhibits/Reverses Liver Injury in a Mouse Model of Diabetes and Obesity
Wednesday, February 26 \| 8:00AM - 11:15AM Obesity Pathogenesis and New Protein Therapeutic Strategies Room: Van Horne A Speaker 10 of 10 Magdalene K. Montgomery, University of Melbourne, Australia Short Talk: Arylsulfatase A (ARSA) is a Novel NASH-Regulated Hepatokine and Potent Regulator of Glycaemic Control
Wednesday, February 26 \| 11:15AM - 5:00PM On Own for Lunch
Wednesday, February 26 \| 11:15AM - 1:00PM Poster Setup Room: Van Horne B/C
Wednesday, February 26 \| 1:00PM - 10:00PM Poster Viewing Room: Van Horne B/C
Wednesday, February 26 \| 4:30PM - 5:00PM Coffee Available Room: Van Horne Foyer
Wednesday, February 26 \| 5:00PM - 7:00PM Pathogenesis of NASH and Liver Fibrosis Room: Van Horne A Speaker 1 of 5 * Yaron Rotman, NIDDK, National Institutes of Health, USA
Wednesday, February 26 \| 5:00PM - 7:00PM Pathogenesis of NASH and Liver Fibrosis Room: Van Horne A Speaker 2 of 5 Bart Staels, Institut Pasteur de Lille, Université Lille, France Pathways in the Transition of Fatty Liver to Active Disease NASH
Wednesday, February 26 \| 5:00PM - 7:00PM Pathogenesis of NASH and Liver Fibrosis Room: Van Horne A Speaker 3 of 5 Utpal B. Pajvani, Columbia University Medical Center, USA Hepatocyte Jagged-Notch Signaling Induces Fibrosis in NASH
Wednesday, February 26 \| 5:00PM - 7:00PM Pathogenesis of NASH and Liver Fibrosis Room: Van Horne A Speaker 4 of 5 Anna Mae Diehl, Duke University, USA Fixing Fatty Livers
Wednesday, February 26 \| 5:00PM - 7:00PM Pathogenesis of NASH and Liver Fibrosis Room: Van Horne A Speaker 5 of 5 Charlotte L. Scott, University of Ghent & VIB, Belgium Short Talk: Lipid-Associated Stress Results in a Loss of Kupffer Cells from the Liver in NAFLD and Repopulation of the Niche by Fatty Liver Associated Macrophages
Wednesday, February 26 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Van Horne B/C No registration fees are used to fund alcohol served at this function.
Wednesday, February 26 \| 7:30PM - 10:00PM Poster Session 3 Room: Van Horne B/C
Thursday, February 27 \| 7:00AM - 8:00AM Breakfast Room: Van Horne B/C
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 1 of 8 * Christian Wolfrum, ETH Zürich, Switzerland
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 2 of 8 Shingo Kajimura, Harvard Medical School, Beth Israel Deaconess Medical Center, USA The Roles of Brown Adipose Tissue Beyond Thermogenesis
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 3 of 8 Karine Clément, INSERM / Sorbonne Universite, France Origins of Adipose Tissue Fibrosis
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Coffee Break
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 5 of 8 Alexander S. Banks, Harvard Medical School, USA Obesity-Linked PPARgamma S273 Phosphorylation Promotes Insulin Resistance through Growth Differentiation Factor 3
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 6 of 8 Silvia Corvera, University of Massachusetts Medical School, USA Mechanisms Controlling Number and Type of Adipocytes
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 7 of 8 Joerg Heeren, University Medical Center Hamburg-Eppendorf, Germany Short Talk: Endothelial Lysosomal Acid Lipase Deficiency Impairs White Adipose Tissue Browning
Thursday, February 27 \| 8:00AM - 11:00AM Adipose Tissue and Organismal Energy Balance Room: Van Horne A Speaker 8 of 8 Alexander Paul Sakers, University of Pennsylvania, USA Short Talk: Lineage Specification of Perivascular Thermogenic Adipocytes
Thursday, February 27 \| 11:00AM - 5:00PM On Own for Lunch
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 1 of 9 * Shirly Pinto, Kallyope, USA
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 2 of 9 Victor Leonard Schuster, Albert Einstein College of Medicine, USA Inhibiting the Prostaglandin Transporter PGT Induces Non-Canonical Thermogenesis at Thermoneutrality
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 3 of 9 Cecile Vernochet, Bill & Melinda Gates Medical Research Institute, USA Adipose GI Signaling is Essential for Liver Fat and Whole Body Glucose Homeostasis
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 4 of 9 Shengping Wang, Johnson and Johnson, USA Weight Loss Via Caloric Restriction Resolves Non-Alcoholic Steatohepatitis (NASH) in Cynomolgus Monkeys
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 5 of 9 Eva C. Thoma, Insphero AG, Switzerland Establishment of a 3D Human NASH Model for High-Throughput Drug Efficacy Testing
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 6 of 9 Caslin Anne Gilroy, University of California at Berkeley, USA The Metabolic microRNA miR-128-1 as a Therapeutic Target for the Treatment of NASH
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 7 of 9 Jean-Francois Thibodeau, Liminal R&D BioSciences Inc., Canada PBI-4050: A Free Fatty Acid Mimetic for the Treatment of NAFLD
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 8 of 9 Jerome Deval, Aligos Therapeutics, USA Preclinical Development of ALG-055009 as a Potent and Selective Thyroid Hormone Receptor Beta Agonist for the Treatment of NASH
Thursday, February 27 \| 2:30PM - 4:30PM Workshop 2: Late-Breaking Drug Targets Room: Van Horne A Speaker 9 of 9 Jin Zhou, Duke-nus, Singapore Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Non-Alcoholic Steatohepatitis (NASH)
Thursday, February 27 \| 4:30PM - 5:00PM Coffee Available Room: Van Horne Foyer
Thursday, February 27 \| 5:00PM - 6:45PM Obesity & NAFLD: Bridging Basic Discoveries and Clinical App lication Room: Van Horne A Speaker 1 of 5 * Rebecca A. Haeusler, Columbia University, USA
Thursday, February 27 \| 5:00PM - 6:45PM Obesity & NAFLD: Bridging Basic Discoveries and Clinical App lication Room: Van Horne A Speaker 2 of 5 Robert K. Semple, University of Edinburgh, UK Mechanisms Linking Human Adipose Tissue, Insulin Resistance and Fatty Liver: Insights from Human Genetics
Thursday, February 27 \| 5:00PM - 6:45PM Obesity & NAFLD: Bridging Basic Discoveries and Clinical App lication Room: Van Horne A Speaker 3 of 5 Jan Borén, University of Gothenburg, Sweden Novel Interventions for NAFLD
Thursday, February 27 \| 5:00PM - 6:45PM Obesity & NAFLD: Bridging Basic Discoveries and Clinical App lication Room: Van Horne A Speaker 4 of 5 Brian Finan, Novo Nordisk, USA Peptide Tri Agonists for the Treatment of Obesity and Diabetes
Thursday, February 27 \| 5:00PM - 6:45PM Obesity & NAFLD: Bridging Basic Discoveries and Clinical App lication Room: Van Horne A Speaker 5 of 5 Emelie Barreby, Karolinska Institutet, Sweden Short Talk: Characterization of Distinct Populations of Liver Macrophages in Obesity and Insulin Resistance
Thursday, February 27 \| 6:45PM - 7:00PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) Room: Van Horne A
Thursday, February 27 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Van Horne B/C No registration fees are used to fund alcohol served at this function.
Thursday, February 27 \| 8:00PM - 11:00PM Entertainment Room: Van Horne B/C Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
Friday, February 28 \| 10:24AM - 10:24AM Departure *Session Chair.